Cargando…
Development of a novel mechanism-based glycolipid adjuvant for vaccination
The inability to elicit strong and durable cellular responses is a major obstacle in the development of successful vaccines, in particular those against malaria. In this regard, the generation of novel adjuvants that will potently boost cell-mediated immunity induced by candidate vaccines is helpful...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981189/ https://www.ncbi.nlm.nih.gov/pubmed/29904582 http://dx.doi.org/10.12688/f1000research.13794.1 |